Universidad Carlos III de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2025

  1. Interplay between iron metabolism, inflammation, and EPO-ERFE-hepcidin axis in RDEB-associated chronic anemia

    Blood Advances, Vol. 9, Núm. 9, pp. 2321-2335

2024

  1. Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study

    Experimental Dermatology, Vol. 33, Núm. 8

2023

  1. Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa

    British Journal of Dermatology, Vol. 189, Núm. 6, pp. 774-776

2020

  1. Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report

    Frontiers in Medicine, Vol. 7